Effect of treatment with compression gloves and compression stockings to prevent paclitaxel-induced peripheral. neuropathy

Effect of treatment with compression gloves and compression stockings to prevent paclitaxel-induced peripheral. neuropathy - gloves and stockings to prevent paclitaxel-induced peripheral neuropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015216

Enrollment

Registered

2014-09-21

Start date

2014-05-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non small cell lung cancer

Interventions

May26,2014-May31,2015

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) planning to treat with paclitaxel and nob-paclitaxel. 2) 20 years old or more 3) no neuropahty before enrollment 4) controlled diabetes mellitus (DM) or no DM 5) no significant skin disorder of extremities

Exclusion criteria

Exclusion criteria: 1) any grade of neurotoxicity 2) no ability to express toxicity 3) significant skin disorder of extremites 4) symptomatic brain metastasis

Design outcomes

Primary

Measure	Time frame
The incidence of peripheral neuropathy in the third cycle before starting	—

Secondary

Measure	Time frame
1) period to development of neurotoxicity (grade 2 or more) 2)proportion of cases who experience contra-lateral neuropathy previous to intervention side. 3) grade of neuropathy 4)relationship among proportion of neuropathy and proportion of completion and effect of chemotherapy. 5) safety of compression gloves and compression stockings.	—

Countries

Japan

Contacts

Public ContactMakoto Maemondo

Miyagi Cancer Center respiratory medicine

maemondo-ma693@niyagi-pho.jp022-384-3151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026